Hyla Fusion Eye Drop contains Sodium Hyaluronate 1.8 mg/ml, a highly effective viscoelastic agent used to provide long-lasting lubrication and hydration to the ocular surface. This ophthalmic solution is specifically formulated to alleviate symptoms associated with dry eye syndrome, including irritation, burning, foreign body sensation, and redness. Sodium Hyaluronate, a naturally occurring polysaccharide, exhibits excellent water-retentive properties, promoting tear film stability and enhancing corneal epithelial healing. Hyla Fusion Eye Drop is suitable for patients experiencing mild to moderate dry eye conditions resulting from environmental factors, prolonged screen exposure, contact lens wear, or post-surgical dryness. The formulation is preservative-free, minimizing the risk of ocular surface toxicity and irritation, making it appropriate for frequent use. Administration involves instilling one or two drops into the affected eye(s) as needed, with dosage adjusted according to symptom severity and clinical response. Hyla Fusion Eye Drop is contraindicated in patients with known hypersensitivity to any component of the formulation. It is recommended to consult an ophthalmologist for proper diagnosis and to rule out underlying causes of dry eye symptoms prior to use. This product supports ocular comfort and visual clarity by restoring moisture and protecting the delicate eye tissues.